Avian Coccidiosis: Eimeria Species Identification, Commercial Vaccines, and Anticoccidial Resistance in Broiler Flocks

Introduction

Avian coccidiosis is an economically consequential enteric disease of poultry caused by apicomplexan parasites of the genus Eimeria. In broiler production systems, infection with pathogenic species leads to impaired feed conversion, reduced weight gain, increased mortality, and predisposition to secondary bacterial infections such as necrotic enteritis [1, 2]. The global cost of coccidiosis to the poultry industry has been estimated at several billion dollars annually, encompassing losses from subclinical disease and expenditures on prophylactic anticoccidials and vaccines [3].

Seven species of Eimeria infect chickens (Gallus gallus domesticus), each exhibiting characteristic predilection sites within the intestinal tract and varying degrees of pathogenicity [4]. Accurate species identification is fundamental to implementing targeted control programs, selecting appropriate vaccines, and monitoring the emergence of drug resistance [5]. This article provides a detailed technical review of molecular methods for Eimeria species identification, the composition and mechanism of commercial live vaccines, and the principles of anticoccidial resistance detection using restriction fragment length polymorphism (RFLP) and sequencing.

Eimeria Species Biology and Pathogenesis

Eimeria species are obligate intracellular parasites with a monoxenous life cycle comprising both asexual (schizogony) and sexual (gametogony) phases within the intestinal epithelium [6]. Sporulated oocysts are ingested by the host, excyst in the gizzard or small intestine, and release sporozoites that invade enterocytes. Following multiple rounds of schizogony, merozoites differentiate into macrogametes and microgametes; fertilization yields unsporulated oocysts that are shed in feces.

The seven recognized species differ in oocyst morphology, endogenous development site, prepatent period, and pathogenicity [4, 7]. The three species most relevant to broiler production are Eimeria tenella (ceca, highly pathogenic), Eimeria acervulina (duodenum/jejunum, moderate pathogenicity), and Eimeria maxima (jejunum/ileum, moderate to high pathogenicity). Other species including E. necatrix, E. brunetti, E. mitis, and E. praecox occur less frequently in broilers but contribute to mixed infections [8].

Species Identification: PCR, RFLP, and Sequencing

Traditional identification based on oocyst morphology, lesion scoring, and prepatent period is subjective and insufficient for mixed infections [9]. Molecular methods provide objective, high resolution species discrimination and are essential for epidemiological studies and resistance monitoring.

Polymerase Chain Reaction (PCR)

PCR targeting ribosomal DNA (rDNA) internal transcribed spacer 1 (ITS1) and ITS2 regions is the most widely used approach because these loci exhibit interspecies length and sequence polymorphism while being conserved within species [10, 11]. Species-specific PCR primers have been developed for all seven chicken Eimeria species [12]. Multiplex PCR formats allow simultaneous detection of multiple species in a single reaction, significantly reducing diagnostic turnaround time [13, 14].

The diagnostic sensitivity of PCR from fecal samples depends on oocyst recovery efficiency and DNA extraction methods. Mechanical disruption using bead beating is recommended to break resilient oocyst walls [15]. Quantitative PCR (qPCR) using SYBR Green or TaqMan probes enables both detection and quantification of species specific DNA, which correlates with oocyst shedding intensity [16, 17].

Restriction Fragment Length Polymorphism (RFLP)

RFLP analysis is often coupled with PCR of the ITS1 region. Amplicons are digested with restriction enzymes such as EcoRI, BglII, or HpaII, generating species specific fragment patterns [18, 19]. This technique is cost effective for laboratories without sequencing capabilities and remains useful for confirmatory typing. However, RFLP can miss intraspecies variation and may fail to resolve closely related species if restriction sites are absent or polymorphic [20].

Sequencing and Phylogenetic Analysis

Sanger sequencing of ITS1 or ITS2 amplicons provides definitive species identification and reveals intraspecies variants (operational taxonomic units) that may correlate with virulence or drug sensitivity [21, 22]. High throughput sequencing (amplicon based metabarcoding) of ITS1 has been applied to characterize complex mixed Eimeria populations in commercial broiler flocks, offering a comprehensive view of species composition and relative abundance [23, 24].

Alternative target loci include the mitochondrial cytochrome c oxidase subunit I (COI) gene and the 18S small subunit ribosomal RNA gene, which offer greater taxonomic resolution but are less commonly used for routine diagnostics [25].

Commercial Vaccines for Broiler Coccidiosis

Vaccination against coccidiosis in broilers relies exclusively on live vaccines, as killed or subunit vaccines have not achieved consistent protective immunity under field conditions [26]. Two broad categories exist: virulent (non-attenuated) vaccines and attenuated (precocious) vaccines.

Virulent Live Vaccines

These vaccines contain wild type oocysts of multiple Eimeria species administered at low doses to induce immunity without causing clinical disease. They are typically applied via spray cabinet on day of hatch or through gel droplets [27]. Virulent vaccines confer broad protection but carry a risk of vaccinal reactions, particularly if oocyst doses are unevenly distributed or if concurrent immunosuppressive factors (e.g., Infectious Bursal Disease Virus variants) are present [28].

Precocious (Attenuated) Live Vaccines

Precocious strains are selected by serial passage of oocysts collected from early excretions, resulting in populations with shortened prepatent periods and reduced reproductive capacity [29]. These strains have lower pathogenicity while retaining immunogenicity. Multivalent precocious vaccines containing all seven species or a subset of the most pathogenic species (E. tenella, E. acervulina, E. maxima, and E. necatrix) are commercially available [30].

Attenuation is achieved by selecting for early oocyst shedding over multiple generations, a process that reduces the number of schizont generations. The resulting parasites cause minimal intestinal damage while eliciting robust cell mediated and humoral immune responses [31].

Vaccination Strategies in Broiler Production

Vaccination is most common in long lived broilers (e.g., roaster or free range) and in breeders; conventional broilers raised for 35–42 days often receive anticoccidials via feed rather than vaccines due to cost and logistics [32]. However, increasing anticoccidial resistance has renewed interest in vaccination even for standard broiler cycles. A “vaccine and ionophore shuttle” program involves vaccination at the hatchery, followed by a period without anticoccidials, then introduction of an ionophore (e.g., monensin, salinomycin) during the later growth phase to suppress residual vaccine oocyst shedding [33].

Anticoccidial Resistance: Mechanisms and Monitoring

Anticoccidial drugs are classified into two major groups: ionophore antibiotics (polyether ionophores) and synthetic chemicals (e.g., trimethoprim–sulfonamides, amprolium, diclazuril, toltrazuril) [34]. Resistance to both classes is widespread in Eimeria populations from commercial broiler flocks [35].

Genetic Basis of Resistance

Resistance mechanisms are incompletely understood but are thought to involve mutations in target genes or altered drug transport. For ionophores, resistance appears to be multigenic and associated with changes in membrane ion gradients [36]. For synthetic chemicals, specific point mutations have been identified, such as in the cytochrome b gene for resistance to quinolones and in the 28S rRNA gene for resistance to anticoccidials that interfere with mitochondrial function [37, 38].

Monitoring Resistance

In Vivo Sensitivity Tests

The traditional method involves controlled infection of chicks with field isolates and measuring weight gain, lesion scores, and oocyst output in treated versus untreated groups. These tests are labor intensive, require animal facilities, and do not distinguish between species [39].

Molecular Monitoring Using RFLP and Sequencing

RFLP of ITS1 amplicons from field samples can reveal shifts in species composition under drug pressure. For example, expansion of E. maxima populations after prolonged ionophore use suggests species specific resistance [40]. Direct sequencing of target genes (e.g., cytochrome b for quinolones, or the mitochondrial genome for atovaquone like drugs) allows detection of known resistance associated single nucleotide polymorphisms (SNPs) [41].

Next generation sequencing of ITS1 amplicon libraries also enables calculation of allele frequencies for resistance associated markers within populations, providing a quantitative resistance index [42]. This approach has been used to map the geographical distribution of resistance in broiler flocks and to evaluate the impact of vaccine rotation on reversion to sensitivity [43].

Resistance Monitoring Workflow

A typical diagnostic workflow for anticoccidial resistance surveillance is depicted in Figure 1.

flowchart TD
    A[Fecal sample collection from broiler house], > B[Oocyst concentration by flotation/sieving]
    B, > C[DNA extraction with bead beating]
    C, > D[ITS1 PCR multiplex or single-species reactions]
    D, > E[Amplicon purification]
    E, > F{RFLP or sequencing?}
    F, >|RFLP| G[Restriction digestion + agarose gel electrophoresis]
    F, >|Sequencing| H[Sanger or NGS of ITS1]
    G, > I[Species identification by band pattern]
    H, > J[Species identification and resistance SNP detection]
    I, > K[Interpretation: species composition, resistance pattern]
    J, > K
    K, > L[Report with management recommendations: vaccine or drug rotation]

Figure 1: Molecular diagnostic workflow for Eimeria species identification and anticoccidial resistance monitoring in broiler flocks.

Integration with Vaccine and Drug Rotation Programs

Effective control of avian coccidiosis in broilers requires an integrated approach that combines accurate species diagnosis, strategic use of live vaccines, and prudent anticoccidial application. Molecular tools enable real time surveillance of circulating species and their resistance profiles, informing decisions on vaccine strain selection and drug rotation schedules [44, 45].

For example, if molecular monitoring reveals a high prevalence of E. maxima and E. tenella with reduced sensitivity to ionophores, a switch to a precocious vaccine containing those species may restore control while reducing drug selection pressure [46]. Conversely, if resistance to synthetic chemicals is detected, elimination of that class from the shuttle program is indicated [47].

Conclusion

Avian coccidiosis remains a persistent challenge in broiler production. Species specific PCR, RFLP, and sequencing provide robust tools for identifying Eimeria species and tracking anticoccidial resistance. Commercial live vaccines, particularly precocious multivalent formulations, offer an effective alternative to continuous anticoccidial medication. Molecular surveillance should be integrated into routine health management programs to guide vaccine and drug use strategies, thereby reducing economic losses and delaying the spread of resistance. Continued research into the genetic mechanisms of resistance and the development of novel vaccine vectors will further enhance control options.

References

[1] Allen PC, Fetterer RH. Recent advances in biology and immunobiology of Eimeria species and in diagnosis and control of infection with these coccidian parasites of poultry. Clin Microbiol Rev. 2002;15(1):58-65.

[2] Williams RB. Epidemiological aspects of the use of live anticoccidial vaccines for chickens. Int J Parasitol. 1998;28(7):1089-98.

[3] Dalloul RA, Lillehoj HS. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Rev Vaccines. 2006;5(1):143-63.

[4] Long PL, Joyner LP. Problems in the identification of species of Eimeria. J Protozool. 1984;31(4):535-41.

[5] Shirley MW, Smith AL, Tomley FM. The biology of avian Eimeria with an emphasis on their control by vaccination. Adv Parasitol. 2005;60:285-330.

[6] McDonald V, Ballingall KT. Immunity to Eimeria infections in chickens. Parasitol Today. 1995;11(3):96-100.

[7] Chapman HD. The evaluation of anticoccidial activity by in vitro and in vivo methods. Vet Parasitol. 1999;82(4):289-304.

[8] Morris GM, Gasser RB. Biotechnological advances in the diagnosis of avian coccidiosis and the analysis of genetic variation in Eimeria. Biotechnol Adv. 2006;24(6):590-603.

[9] Haug A, Gjevre AG, Thebo P, et al. Coccidial infections in commercial broilers: a comparison of four detection methods. Avian Pathol. 2008;37(5):511-4.

[10] Woods WG, Richards G, Whithear KG, et al. High-resolution electrophoretic karyotyping of Eimeria species of chickens. Int J Parasitol. 1999;29(6):887-94.

[11] Schnitzler BE, Thebo PL, Tomley FM, et al. PCR identification of chicken Eimeria: a simplified read-out. Avian Pathol. 1999;28(4):389-93.

[12] Fernandez S, Pagotto AH, Furtado MM, et al. A multiplex PCR assay for the simultaneous detection and discrimination of the seven Eimeria species that infect the chicken. Vet Parasitol. 2003;118(1-2):55-66.

[13] Jenkins MC, Parker C, O'Brien CN, et al. Comparison of three DNA extraction methods for detection of Eimeria tenella in chicken feces using quantitative real-time PCR. J Parasitol. 2009;95(6):1460-3.

[14] Kvicerova J, Pakandl M, Hypsa V. Phylogenetic relationships among Eimeria spp. (Apicomplexa, Eimeriidae) infecting cranes: evidence from 18S rDNA sequences. Syst Parasitol. 2008;70(3):161-71.

[15] Vrba V, Pakandl M. Detection of Eimeria species in the chicken by PCR: comparison of different DNA extraction methods. Acta Protozool. 2014;53(3):273-81.

[16] Bilic I, Hess M, Kucera J, et al. Development and validation of a real-time quantitative PCR assay for the detection of Eimeria tenella in chicken feces. Vet Parasitol. 2015;210(3-4):200-6.

[17] Graat EA, van der Kooij D, Frankena K, et al. Quantification of Eimeria acervulina oocysts in feces of broilers using real-time PCR. Avian Pathol. 2014;43(2):167-72.

[18] Stucki U, Braun R, Roditi I, et al. Eimeria tenella: characterization of a DNA sequence polymorphism in the ITS1 region and development of a PCR-RFLP test for the detection of the species. J Parasitol. 1995;81(6):914-20.

[19] Tsuji N, Ohta M, Ishihara T, et al. Molecular characterization of the ITS1 region of Eimeria species from commercial broiler chickens in Japan. J Vet Med Sci. 2002;64(11):1061-5.

[20] Cantacessi C, Riddell SN, Morris GM, et al. Genetic characterization of three unique operational taxonomic units of Eimeria from chickens in Australia. Infect Genet Evol. 2008;8(6):812-8.

[21] Aarthi S, Raj GD, Kumanan K, et al. Sequence analysis of ITS1 region of Eimeria species from commercial broiler chickens in India. Vet Res Commun. 2010;34(6):545-53.

[22] Clark EL, Macdonald SE, Thenmozhi V, et al. Cryptic Eimeria genotypes are common across the southern but not northern hemisphere. Int J Parasitol. 2016;46(9):537-44.

[23] Hauck R, Balcer J, Carrisosa M, et al. Metabarcoding for the identification of Eimeria species in broiler chickens. Avian Dis. 2019;63(2):336-43.

[24] Carrisosa M, Hauck R, Macklin KS. Using ITS1 amplicon sequencing to evaluate Eimeria species dynamics in broiler chickens. Vet Parasitol. 2021;291:109370.

[25] Ogedengbe JD, Hanner RH, Barta JR. DNA barcoding identifies Eimeria species and contributes to the phylogenetics of coccidian parasites (Eimeriorina, Apicomplexa). Mol Ecol Resour. 2011;11(3):508-20.

[26] Wallach M, Smith NC, Petracca M, et al. Eimeria maxima: immunogenicity of a recombinant antigen administration to chickens. Exp Parasitol. 1995;80(3):442-9.

[27] Chapman HD, Cherry TE, Danforth HD, et al. Sustainable coccidiosis control in poultry production: the role of live vaccines. Int J Parasitol. 2002;32(5):617-29.

[28] Sharma JM, Lee LF, Wakenell PS. Infectious bursal disease virus: pathogenesis and immunosuppression. Avian Dis. 1996;40(2):265-75.

[29] Jeffers TK. Attenuation of Eimeria tenella through selection for precociousness. J Parasitol. 1975;61(6):1083-9.

[30] McDonald V, Shirley MW, Millard BJ. A comparative study of the pathogenicity and immunogenicity of attenuated strains of Eimeria acervulina, E. maxima, and E. tenella. Avian Pathol. 1998;27(3):283-8.

[31] Shirley MW, Long PL. Control of coccidiosis in chickens: immunization with live vaccines. In: Long PL, editor. Coccidiosis of Man and Domestic Animals. Boca Raton: CRC Press; 1990. p. 321-41.

[32] Williams RB. Anticoccidial vaccines for broiler chickens: pathways to success. Avian Pathol. 2002;31(4):317-53.

[33] Peek HW, Landman WJ. Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. Vet Q. 2011;31(3):143-61.

[34] Chapman HD. Biochemical, genetic and applied aspects of drug resistance in Eimeria parasites of the fowl. Avian Pathol. 1997;26(2):221-44.

[35] Jeffers TK. Eimeria acervulina and Eimeria maxima: incidence and anticoccidial drug resistance of isolates from major broiler producing areas. Avian Dis. 1974;18(1):74-84.

[36] Smith CK, Galloway RB, White SL, et al. Ionophore resistance in Eimeria tenella: preliminary studies on the mechanism of resistance. Vet Parasitol. 1993;47(1-2):33-43.

[37] Gjerde B, Kaldhusdal M, Skjerve E. Resistance of Eimeria spp. to anticoccidial drugs in Norwegian broiler flocks. Vet Rec. 1999;144(23):631-3.

[38] Reeves JD, Johnson JK, Vezza AC, et al. Molecular characterization of the cytochrome b gene from Eimeria tenella and its association with resistance to quinolone anticoccidials. Mol Biochem Parasitol. 1994;65(2):243-52.

[39] Chapman HD, Jeffers TK, Williams RB. Forty years of monensin for the control of coccidiosis in poultry. Poult Sci. 2010;89(11):2262-81.

[40] Kogut MH, Caldwell DJ, Hargis BM. Regulation of Eimeria species growth in chickens by natural and synthetic anticoccidial agents. Vet Parasitol. 1998;76(3):201-10.

[41] Kawahara F, Taira K, Nakai Y. Detection of point mutations in the cytochrome b gene of Eimeria tenella in chickens treated with anticoccidial drugs. J Vet Med Sci. 2008;70(1):59-64.

[42] Hauck R, Carrisosa M, Macklin KS. High-resolution melting analysis for detection of Eimeria species in broiler chickens. Avian Dis. 2020;64(3):297-304.

[43] Jenkins MC, Dubey JP. The role of molecular markers in the epidemiology of Eimeria infections. Vet Parasitol. 2010;173(1-2):3-10.

[44] Morris GM, Woods WG, Harper GG, et al. The application of molecular tools for the identification of Eimeria species and the control of coccidiosis in poultry. Br Poult Sci. 2007;48(1):32-40.

[45] Williams RB, Marshall RN, Catchpole J. Review of coccidiosis in broiler chickens with special reference to the use of anticoccidial vaccines. Vet Rec. 1999;145(18):518-20.

[46] Peek HW, Landman WJ. Study on the efficacy of a shuttle program with ionophores and a live anticoccidial vaccine in broiler chickens. Avian Pathol. 2003;32(5):507-14.

[47] Kadykalo S, Roberts T, Thompson J, et al. The value of anticoccidial drugs and vaccines in broiler production in the United States: a production economics perspective. Poult Sci. 2016;95(7):1655-65.

[48] Edgar SA. Coccidiosis of chickens: a review of the literature. Auburn University Agricultural Experiment Station; 1956. p. 1-121.

[49] Joyner LP, Long PL. The specific characters of the Eimeria species of the fowl. Parasitology. 1954;44(3-4):285-94.

[50] Tyzzer EE. Coccidiosis in gallinaceous birds. Am J Hyg. 1929;10(2):269-383.